Life Sciences Intellectual Property Summit 2011


Life Sciences Intellectual Property Summit 2011

Thursday, May 19
Estancia La Jolla Hotel & Spa
9700 N. Torrey Pines Road
La Jolla, CA

In cooperation with:


Keynote address Speaker: Nathan Fletcher, State Assemblyman representing California’s 75th District

Confirmed in-house counsel panelists include:

  • Charles Berkman, Vice President, General Counsel & Secretary, Ligand Pharmaceuticals
  • Deb Gordon, General Counsel, Ventana Medical Systems
  • Matthew Onaitis, Senior Vice President, General Counsel and Secretary, Somaxon Pharmaceuticals
  • William Scarff, Chief Litigation Counsel, Allergan, Inc.

Panel Topics

Qui Tam and Fraud Claims – Current Strategies and Developments
Best practices for keeping government investigators away from your pharmaceutical and medical device businesses and what to do if those measures fail.

The Alchemy of Personalized Medicine: Turning Biomarkers into Gold
Best practices and innovative approaches for securing patent and regulatory exclusivities for personalized medicine-based diagnostics and therapeutics.

Protecting Your Brand Name: Obtaining PTO and FDA Approval
Update on obtaining FDA approval of biotech and pharma trademarks, tips for how to pick good marks, and the interplay between FDA-approval and registration at the U.S. Patent and Trademark Office.

You Know It Is Coming: Preparing for the Paragraph IV Letter
How a branded company can prepare prior to receipt of a Paragraph IV letter, from the perspective of both inside and outside counsel.

May 19, 2011
Estancia La Jolla Hotel & Spa
La Jolla, CAOutlookbutton47.gif

Fish & Richardson will apply for up to 3.5 hours of CLE credit in most states.

For more information or to RSVP, contact Liz Giliberti at giliberti@fr.com
To subscribe to Fish & Richardson newsletters, go to www.fr.com/subscriptions.